KalVista Pharmaceuticals, Inc. Income Statement

Income Statement Dec2013 Dec2014 Apr2015 Dec2015 Apr2016 Apr2017 Apr2018 Apr2019 Apr2020 Apr2021 Apr2022 Apr2023 Apr2024 Apr2025
Revenue & cost
Revenue 0.41M0.03M1.80M0.03M2.13M1.50M8.39M16.13M12.69M50.00M-5.79M
Gross Profit 0.41M0.03M1.80M0.03M2.13M1.50M8.39M16.13M12.69M50.00M-5.79M
Operating items
Research & Development 4.23M8.29M8.29M16.20M14.66M12.67M18.24M35.02M40.19M41.29M70.17M80.28M86.17M71.71M
Selling, General & Administrative 1.40M3.41M1.61M4.87M2.65M11.18M8.86M10.93M13.03M16.64M26.45M30.59M54.28M116.29M
Restructuring Costs 35.80M53.43M
Other Operating Expenses -35.80M-53.43M
Operating Expenses 5.63M11.71M9.89M21.07M17.31M23.84M27.10M45.95M53.22M57.92M96.61M110.87M140.44M188.00M
Operating Income -5.22M-11.68M-8.09M-21.04M-15.18M-22.34M-18.70M-29.82M-40.53M-57.92M-96.61M-110.87M-140.44M-188.00M
EBIT -5.22M-11.68M-8.09M-21.04M-15.18M-22.34M-18.70M-29.82M-40.53M-57.92M-96.61M-110.87M-140.44M-188.00M
Non-operating items
Interest & Investment Income 0.00M0.00M0.02M0.01M0.05M0.04M0.08M1.40M1.83M0.90M1.09M2.23M3.90M6.43M
Other Non Operating Income -0.06M-0.60M0.84M-3.18M2.03M2.33M4.39M7.68M9.83M9.93M14.72M15.64M9.77M4.81M
Non Operating Income -0.46M-1.68M0.86M-3.81M3.75M3.74M4.39M9.13M11.29M11.68M14.72M17.96M13.80M7.94M
Net income details
EBT -5.62M-12.76M-8.07M-22.22M-15.13M-18.60M-15.80M-20.69M-29.24M-82.34M-82.34M-92.91M-126.64M-180.05M
Tax Provisions 0.12M-0.12M3.40M
Profit After Tax -5.68M-13.36M-7.23M-24.85M-11.44M-18.60M-15.80M-20.82M-29.12M-46.24M-82.34M-92.91M-126.64M-183.44M
Income from Continuing Operations -5.62M-12.76M-8.07M-22.22M-15.13M-18.60M-15.80M-20.82M-29.12M-82.34M-82.34M-92.91M-126.64M-183.45M
Consolidated Net Income -5.62M-12.76M-8.07M-22.22M-15.13M-18.60M-15.80M-20.82M-29.12M-82.34M-82.34M-92.91M-126.64M-183.45M
Income towards Parent Company -5.62M-12.76M-8.07M-22.22M-15.13M-18.60M-15.80M-20.82M-29.12M-82.34M-82.34M-92.91M-126.64M-183.45M
Net Income towards Common Stockholders -5.62M-12.76M-9.20M-22.22M-15.47M-20.77M-15.80M-20.82M-29.12M-82.34M-82.34M-92.91M-126.64M-183.45M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.66M1.66M1.88M1.88M9.71M10.80M17.25M17.85M24.31M24.54M34.23M42.19M49.72M
Shares Outstanding (Diluted Average) 17.75M36.79M
EBITDA -5.22M-11.68M-7.38M-21.04M-13.68M-21.17M-14.27M-21.63M-29.07M-45.79M-84.77M-92.11M-127.07M-185.17M
Tax Rate 0.42%